Article Details

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET Immunotherapy Drug Candidate

Retrieved on: 2021-01-12 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET Immunotherapy Drug Candidate. View article details on hiswai:

Excerpt

Dragonfly Therapeutics a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease, today ...

Article found on: investingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo